Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer.

Lindström LS, Yau C, Czene K, Thompson CK, Hoadley KA, Van't Veer LJ, Balassanian R, Bishop JW, Carpenter PM, Chen YY, Datnow B, Hasteh F, Krings G, Lin F, Zhang Y, Nordenskjöld B, Stål O, Benz CC, Fornander T, Borowsky AD, Esserman LJ; STO Trialists Group.

J Natl Cancer Inst. 2018 Jul 1;110(7):726-733. doi: 10.1093/jnci/djx270.

2.

T1ρ/T2 mapping and histopathology of degenerative cartilage in advanced knee osteoarthritis.

Kester BS, Carpenter PM, Yu HJ, Nozaki T, Kaneko Y, Yoshioka H, Schwarzkopf R.

World J Orthop. 2017 Apr 18;8(4):350-356. doi: 10.5312/wjo.v8.i4.350. eCollection 2017 Apr 18.

3.

Migration of breast cancer cell lines in response to pulmonary laminin 332.

Carpenter PM, Sivadas P, Hua SS, Xiao C, Gutierrez AB, Ngo T, Gershon PD.

Cancer Med. 2017 Jan;6(1):220-234. doi: 10.1002/cam4.957. Epub 2016 Nov 22.

4.

Predicting Responses to Neoadjuvant Chemotherapy in Breast Cancer: ACRIN 6691 Trial of Diffuse Optical Spectroscopic Imaging.

Tromberg BJ, Zhang Z, Leproux A, O'Sullivan TD, Cerussi AE, Carpenter PM, Mehta RS, Roblyer D, Yang W, Paulsen KD, Pogue BW, Jiang S, Kaufman PA, Yodh AG, Chung SH, Schnall M, Snyder BS, Hylton N, Boas DA, Carp SA, Isakoff SJ, Mankoff D; ACRIN 6691 investigators.

Cancer Res. 2016 Oct 15;76(20):5933-5944. Epub 2016 Aug 15.

5.

Massive pneumatosis without necrosis: A case report of Clostridium perfringens sepsis in an extremely low birth weight infant.

Nicolau Y, Bany-Mohammed F, Carpenter PM, Uy C.

J Neonatal Perinatal Med. 2015;8(3):257-61. doi: 10.3233/NPM-15814066.

PMID:
26485548
6.

"Score the Core" Web-based pathologist training tool improves the accuracy of breast cancer IHC4 scoring.

Engelberg JA, Retallack H, Balassanian R, Dowsett M, Zabaglo L, Ram AA, Apple SK, Bishop JW, Borowsky AD, Carpenter PM, Chen YY, Datnow B, Elson S, Hasteh F, Lin F, Moatamed NA, Zhang Y, Cardiff RD.

Hum Pathol. 2015 Nov;46(11):1694-704. doi: 10.1016/j.humpath.2015.07.008. Epub 2015 Jul 29.

PMID:
26410019
7.

Background Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.

Chen JH, Yu HJ, Hsu C, Mehta RS, Carpenter PM, Su MY.

Transl Oncol. 2015 Jun;8(3):204-9. doi: 10.1016/j.tranon.2015.04.001.

8.

A randomized, double-blind, placebo-controlled phase II clinical trial of lovastatin for various endpoints of melanoma pathobiology.

Linden KG, Leachman SA, Zager JS, Jakowatz JG, Viner JL, McLaren CE, Barr RJ, Carpenter PM, Chen WP, Elmets CA, Tangrea JA, Lim SJ, Cochran AJ, Meyskens FL Jr.

Cancer Prev Res (Phila). 2014 May;7(5):496-504. doi: 10.1158/1940-6207.CAPR-13-0189. Epub 2014 Mar 10.

9.

Generation of "virtual" control groups for single arm prostate cancer adjuvant trials.

Jia Z, Lilly MB, Koziol JA, Chen X, Xia XQ, Wang Y, Skarecky D, Sutton M, Sawyers A, Ruckle H, Carpenter PM, Wang-Rodriguez J, Jiang J, Deng M, Pan C, Zhu JG, McLaren CE, Gurley MJ, Lee C, McClelland M, Ahlering T, Kattan MW, Mercola D.

PLoS One. 2014 Jan 21;9(1):e85010. doi: 10.1371/journal.pone.0085010. eCollection 2014.

10.

Evaluation of ultra-deep targeted sequencing for personalized breast cancer care.

Harismendy O, Schwab RB, Alakus H, Yost SE, Matsui H, Hasteh F, Wallace AM, Park HL, Madlensky L, Parker B, Carpenter PM, Jepsen K, Anton-Culver H, Frazer KA.

Breast Cancer Res. 2013 Dec 10;15(6):R115. doi: 10.1186/bcr3584.

11.

Impact of factors affecting the residual tumor size diagnosed by MRI following neoadjuvant chemotherapy in comparison to pathology.

Chen JH, Bahri S, Mehta RS, Carpenter PM, McLaren CE, Chen WP, Fwu PT, Hsiang DJ, Lane KT, Butler JA, Su MY.

J Surg Oncol. 2014 Feb;109(2):158-67. doi: 10.1002/jso.23470. Epub 2013 Oct 28.

12.

Validation and workflow optimization of human epidermal growth factor receptor 2 testing using INFORM HER2 dual-color in situ hybridization.

Lim SJ, Cantillep A, Carpenter PM.

Hum Pathol. 2013 Nov;44(11):2590-6. doi: 10.1016/j.humpath.2013.07.005. Epub 2013 Sep 25.

PMID:
24075600
13.

Left-sided gastroschisis with placenta findings: case report and literature review.

Shi Y, Farinelli CK, Chang MS, Carpenter PM.

Int J Clin Exp Pathol. 2012;5(3):243-6. Epub 2012 Mar 25. Review.

14.

Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile.

Kuzucan A, Chen JH, Bahri S, Mehta RS, Carpenter PM, Fwu PT, Yu HJ, Hsiang DJ, Lane KT, Butler JA, Feig SA, Su MY.

Clin Breast Cancer. 2012 Apr;12(2):110-8. doi: 10.1016/j.clbc.2012.01.009.

15.

Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging.

Chen JH, Bahri S, Mehta RS, Kuzucan A, Yu HJ, Carpenter PM, Feig SA, Lin M, Hsiang DJ, Lane KT, Butler JA, Nalcioglu O, Su MY.

Radiology. 2011 Dec;261(3):735-43. doi: 10.1148/radiol.11110814. Epub 2011 Aug 30.

16.

Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia.

Carroll RE, Benya RV, Turgeon DK, Vareed S, Neuman M, Rodriguez L, Kakarala M, Carpenter PM, McLaren C, Meyskens FL Jr, Brenner DE.

Cancer Prev Res (Phila). 2011 Mar;4(3):354-64. doi: 10.1158/1940-6207.CAPR-10-0098. Erratum in: Cancer Prev Res (Phila). 2012 Dec;5(12):1407. Dosage error in article text.

17.

Characterization of Pure Ductal Carcinoma In Situ on Dynamic Contrast-Enhanced MR Imaging: Do Nonhigh Grade and High Grade Show Different Imaging Features?

Chan S, Chen JH, Agrawal G, Lin M, Mehta RS, Carpenter PM, Nalcioglu O, Su MY.

J Oncol. 2010;2010. pii: 431341. doi: 10.1155/2010/431341. Epub 2010 Sep 21.

18.

Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors.

Qi J, Nakayama K, Cardiff RD, Borowsky AD, Kaul K, Williams R, Krajewski S, Mercola D, Carpenter PM, Bowtell D, Ronai ZA.

Cancer Cell. 2010 Jul 13;18(1):23-38. doi: 10.1016/j.ccr.2010.05.024.

19.

Angiogenesis in the progression of breast ductal proliferations.

Carpenter PM, Chen WP, Mendez A, McLaren CE, Su MY.

Int J Surg Pathol. 2011 Jun;19(3):335-41. doi: 10.1177/1066896909333511. Epub 2009 Apr 29.

20.

Motility induction in breast carcinoma by mammary epithelial laminin 332 (laminin 5).

Carpenter PM, Dao AV, Arain ZS, Chang MK, Nguyen HP, Arain S, Wang-Rodriguez J, Kwon SY, Wilczynski SP.

Mol Cancer Res. 2009 Apr;7(4):462-75. doi: 10.1158/1541-7786.MCR-08-0148. Epub 2009 Apr 7.

21.

Residual breast cancer diagnosed by MRI in patients receiving neoadjuvant chemotherapy with and without bevacizumab.

Bahri S, Chen JH, Mehta RS, Carpenter PM, Nie K, Kwon SY, Yu HJ, Nalcioglu O, Su MY.

Ann Surg Oncol. 2009 Jun;16(6):1619-28. doi: 10.1245/s10434-009-0441-5. Epub 2009 Mar 31.

22.

Rational and successful use of carboplatin and albumin-bound paclitaxel in a patient with recurrent metaplastic carcinoma who presented with multi-organ tumor emboli.

Mehta RS, Schubbert T, Marshall J, Carpenter PM.

Clin Breast Cancer. 2009 Feb;9(1):56-9. doi: 10.3816/CBC.2009.n.011.

PMID:
19299243
23.

Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial.

Meyskens FL Jr, McLaren CE, Pelot D, Fujikawa-Brooks S, Carpenter PM, Hawk E, Kelloff G, Lawson MJ, Kidao J, McCracken J, Albers CG, Ahnen DJ, Turgeon DK, Goldschmid S, Lance P, Hagedorn CH, Gillen DL, Gerner EW.

Cancer Prev Res (Phila). 2008 Jun;1(1):32-8. doi: 10.1158/1940-6207.CAPR-08-0042.

24.

Laminin 5 expression in metaplastic breast carcinomas.

Carpenter PM, Wang-Rodriguez J, Chan OT, Wilczynski SP.

Am J Surg Pathol. 2008 Mar;32(3):345-53. doi: 10.1097/PAS.0b013e3181592201. Erratum in: Am J Surg Pathol. 2009 Feb;33(2):322.

PMID:
18300817
25.

TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases.

Yarosh W, Barrientos T, Esmailpour T, Lin L, Carpenter PM, Osann K, Anton-Culver H, Huang T.

Cancer Res. 2008 Feb 1;68(3):693-9. doi: 10.1158/0008-5472.CAN-07-5012.

26.

Magnetic resonance imaging in predicting pathological response of triple negative breast cancer following neoadjuvant chemotherapy.

Chen JH, Mehta RS, Carpenter PM, Nalcioglu O, Su MY.

J Clin Oncol. 2007 Dec 10;25(35):5667-9. No abstract available.

PMID:
18065744
27.

Triple-negative breast cancer: MRI features in 29 patients.

Chen JH, Agrawal G, Feig B, Baek HM, Carpenter PM, Mehta RS, Nalcioglu O, Su MY.

Ann Oncol. 2007 Dec;18(12):2042-3. Epub 2007 Nov 20. No abstract available.

PMID:
18029970
28.

MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy.

Chen JH, Feig B, Agrawal G, Yu H, Carpenter PM, Mehta RS, Nalcioglu O, Su MY.

Cancer. 2008 Jan 1;112(1):17-26. Erratum in: Cancer. 2008 Apr 1;112(7):1642. Feig, Byon [corrected to Feig, Byron].

29.

Auricular angioleiomyoma: a case report and review of the literature.

Wirth GA, Sundine MJ, Kong AP, Carpenter PM.

Ear Nose Throat J. 2007 May;86(5):281-3. Review.

PMID:
17580807
30.

Cannabinoid concentrations in hair from documented cannabis users.

Huestis MA, Gustafson RA, Moolchan ET, Barnes A, Bourland JA, Sweeney SA, Hayes EF, Carpenter PM, Smith ML.

Forensic Sci Int. 2007 Jul 4;169(2-3):129-36. Epub 2006 Sep 11.

31.

Increased epithelial cadherin expression among Japanese intestinal-type gastric cancers compared with specimens from American patients of European descent.

Theuer CP, Al-Kuran R, Akiyama Y, Okumura M, Ziogas A, Carpenter PM.

Am Surg. 2006 Apr;72(4):332-8.

PMID:
16676859
32.

The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi.

Hardison JL, Wrightsman RA, Carpenter PM, Kuziel WA, Lane TE, Manning JE.

Infect Immun. 2006 Jan;74(1):135-43.

33.
34.

Pharmacokinetic parameters analyzed from mr contrast enhancement kinetics of multiple malignant and benign breast lesions detected in the same patients.

Su MY, Yu HJ, Carpenter PM, McLaren CE, Nalcioglu O.

Technol Cancer Res Treat. 2005 Jun;4(3):255-63.

PMID:
15896081
35.

Nuclear morphometry and molecular biomarkers of actinic keratosis, sun-damaged, and nonexposed skin.

Carpenter PM, Linden KG, McLaren CE, Li KT, Arain S, Barr RJ, Hite P, Sun JD, Meyskens FL Jr.

Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):1996-2002.

36.

VEGF(121) and VEGF(165) regulate blood vessel diameter through vascular endothelial growth factor receptor 2 in an in vitro angiogenesis model.

Nakatsu MN, Sainson RC, Pérez-del-Pulgar S, Aoto JN, Aitkenhead M, Taylor KL, Carpenter PM, Hughes CC.

Lab Invest. 2003 Dec;83(12):1873-85.

PMID:
14691306
37.

The role of hyaluronan in mesothelium-induced motility of ovarian carcinoma cells.

Carpenter PM, Dao AV.

Anticancer Res. 2003 Sep-Oct;23(5A):3985-90.

PMID:
14666707
38.

Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of fibroblasts and Angiopoietin-1.

Nakatsu MN, Sainson RC, Aoto JN, Taylor KL, Aitkenhead M, Pérez-del-Pulgar S, Carpenter PM, Hughes CC.

Microvasc Res. 2003 Sep;66(2):102-12.

PMID:
12935768
39.

Chemoprevention of nonmelanoma skin cancer: experience with a polyphenol from green tea.

Linden KG, Carpenter PM, McLaren CE, Barr RJ, Hite P, Sun JD, Li KT, Viner JL, Meyskens FL.

Recent Results Cancer Res. 2003;163:165-71; discussion 264-6. Review.

PMID:
12903852
40.

Paranuaclear E-cadherin in gastric adenocarcinoma.

Carpenter PM, Al-Kuran RA, Theuer CP.

Am J Clin Pathol. 2002 Dec;118(6):887-94.

PMID:
12472282
41.

Measuring microvascular density in tumors by digital dissection.

Samoszuk M, Leonor L, Espinoza F, Carpenter PM, Nalcioglu O, Su MY.

Anal Quant Cytol Histol. 2002 Feb;24(1):15-22.

PMID:
11865945
42.

Human kallikrein 2 (hK2), but not prostate-specific antigen (PSA), rapidly complexes with protease inhibitor 6 (PI-6) released from prostate carcinoma cells.

Saedi MS, Zhu Z, Marker K, Liu RS, Carpenter PM, Rittenhouse H, Mikolajczyk SD.

Int J Cancer. 2001 Nov;94(4):558-63.

43.

C1qR(P), a myeloid cell receptor in blood, is predominantly expressed on endothelial cells in human tissue.

Fonseca MI, Carpenter PM, Park M, Palmarini G, Nelson EL, Tenner AJ.

J Leukoc Biol. 2001 Nov;70(5):793-800.

PMID:
11698500
44.

Breast imaging case of the day. Fat necrosis of the breast.

Cyrlak D, Carpenter PM.

Radiographics. 1999 Oct;19 Spec No:S80-3. No abstract available.

PMID:
10517446
45.

Breast imaging case of the day. Intramammary and axillary lymph node metastases from infiltrating lobular carcinoma of the breast.

Cyrlak D, Carpenter PM.

Radiographics. 1999 Oct;19 Spec No:S73-9. No abstract available.

PMID:
10517445
46.

Breast imaging case of the day. Pseudoangiomatous stromal hyperplasia.

Cyrlak D, Carpenter PM.

Radiographics. 1999 Jul-Aug;19(4):1086-8. No abstract available.

PMID:
10464812
47.

Breast imaging case of the day. Tubular carcinoma and fibroadenoma.

Cyrlak D, Carpenter PM, Rawal NB.

Radiographics. 1999 May-Jun;19(3):813-6. No abstract available.

PMID:
10336205
48.

Characterization of N-ethyl-N-nitrosourea-induced malignant and benign breast tumors in rats by using three MR contrast agents.

Su MY, Wang Z, Carpenter PM, Lao X, Mühler A, Nalcioglu O.

J Magn Reson Imaging. 1999 Feb;9(2):177-86.

PMID:
10077011
49.

Breast imaging case of the day. Florid sclerosing adenosis.

Cyrlak D, Carpenter PM, Rawal NB.

Radiographics. 1999 Jan-Feb;19(1):245-7. No abstract available.

PMID:
9925403
50.

Mammary epithelium-induced motility of MCF-7 cells.

Carpenter PM, Nguyen HP.

Anticancer Res. 1998 Mar-Apr;18(2A):1063-8.

PMID:
9615766

Supplemental Content

Loading ...
Support Center